Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
530
-
Total 13F shares, excl. options
-
175M
-
Shares change
-
+1.24M
-
Total reported value, excl. options
-
$15.4B
-
Value change
-
+$129M
-
Put/Call ratio
-
0.71
-
Number of buys
-
248
-
Number of sells
-
-212
-
Price
-
$88.35
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q4 2021
626 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q4 2021.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 530 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 175M shares
of 192M outstanding shares and own 91.17% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (17.8M shares), VANGUARD GROUP INC (16.4M shares), Dodge & Cox (14.8M shares), BlackRock Inc. (13.9M shares), Capital Research Global Investors (12.7M shares), BAKER BROS. ADVISORS LP (7.62M shares), AMERIPRISE FINANCIAL INC (6.55M shares), STATE STREET CORP (5.32M shares), Clearbridge Investments, LLC (5.26M shares), and JANUS HENDERSON GROUP PLC (3.89M shares).
This table shows the top 530 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.